Project Details
Description
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of ZYC101a in the Treatment of High-Grade Cervical Intraepithelial Lesions
| Status | Finished |
|---|---|
| Effective start/end date | 10/24/05 → 1/27/11 |
Funding
- MGI PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.